McCormick & Co. Inc. 10-Q Summary
Business Context and Reporting Period
Company: McCormick & Company, Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: May 31, 2010
Business Overview: Global leader in spices, herbs, seasonings, and flavors operating in two segments: Consumer (retail) and Industrial (food manufacturers/service). Approximately 40% of sales are outside the U.S.
Key Financial Metrics
| Metric (in millions) | 3 Months Ended May 31, 2010 | 6 Months Ended May 31, 2010 |
|---|---|---|
| Net Sales | $798.3 | $1,562.8 |
| Gross Profit | $326.7 | $636.9 |
| Gross Margin | 40.9% | 40.8% |
| Operating Income | $97.5 | $198.4 |
| Net Income | $66.2 | $134.2 |
| Diluted EPS | $0.49 | $1.00 |
| Cash Flow from Operations | N/A (Quarterly) | $65.2 |
| Total Debt (Short + Long Term) | $1,004.1 | $1,004.1 |
| Cash and Equivalents | $23.1 | $23.1 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.4% (Q2) and 5.9% (YTD) compared to the prior year. Growth was driven by favorable foreign currency exchange rates (3.7% Q2, 4.2% YTD), volume, and product mix. Organic growth (excluding FX) was 1.7% for both periods.
- Margin Expansion: Gross profit margins improved by 100 basis points in Q2 and 110 basis points YTD, exceeding the 50 basis point full-year projection. This was driven by the Comprehensive Continuous Improvement (CCI) program and favorable business mix.
- Profitability: Operating income rose 18.2% (Q2) and 15.1% (YTD). Net income increased 30.6% (Q2) and 23.8% (YTD).
- Restructuring: The company incurred no restructuring charges in 2010, compared to $6.9 million (Q2) and $7.3 million (YTD) in 2009. The restructuring program was completed in November 2009.
- Segment Performance:
- Consumer: Sales up 4.0% (Q2) and 5.9% (YTD). Operating income (ex-restructuring) declined slightly in Q2 due to increased marketing spend ($6.8M incremental) but grew 1.4% YTD.
- Industrial: Sales up 7.3% (Q2) and 5.9% (YTD). Operating income (ex-restructuring) surged 65.5% (Q2) and 49.1% (YTD), aided by higher sales, CCI savings, and a one-time $7.5M expense in the prior year related to a U.K. distributor bankruptcy.
Guidance, Outlook, and Risks
- 2010 Outlook:
- Sales: Expected to grow 2% to 4% in local currency.
- Earnings Per Share: Expected to grow 6% to 8%.
- Margins: Projected gross profit margin increase of at least 50 basis points for the full year.
- Marketing: Anticipated total increase of $20 million over 2009 levels, largely incurred in the first half.
- Capital Allocation:
- Dividends: Increased to $0.26 per share (Q2) and $0.52 (YTD).
- Share Repurchases: Board authorized a new $400 million program in June 2010. Expect to spend $50–$100 million by year-end.
- Acquisitions: Signed agreement in June 2010 to purchase a 26% non-controlling interest in Eastern Condiments (India) for approx. $35 million.
- Risks and Contingencies:
- Product Recall: Incurred $4.4 million in costs in Q1 2010 related to a product recall.
- Foreign Exchange: Significant impact on reported results; strengthening U.S. dollar reduced assets and comprehensive income.
- Raw Materials: Volatility in costs for dairy, pepper, wheat, and soybean oil remains a risk, though partially offset by pricing and cost savings.
- EMEA Consumer Market: Management remains cautious regarding the outlook for the EMEA consumer business due to weak demand and inventory pullbacks in smaller markets.
Investor Verification Checklist
- Organic Growth Rate: Verify the 1.7% organic sales growth excluding the significant favorable foreign currency impact.
- Marketing ROI: Assess the impact of the $20 million increased marketing spend on future sales growth versus current margin compression.
- EMEA Performance: Monitor the "cautious" outlook for the EMEA consumer segment and potential inventory destocking risks.
- Product Recall Costs: Confirm that the $4.4 million recall cost was a one-time event and assess any lingering brand impact.
- Debt Reduction: Track the reduction of debt related to the Lawry's acquisition and the execution of the new $400 million share repurchase program.
- Eastern Condiments Deal: Verify the regulatory approval and closing timeline for the 26% stake in the Indian spice company.